Objective  To explore the current research status and trends in the field of pharmaceutical care in China based on bibliometrics, in order to provide references for the development of pharmaceutical care.

Methods  Relevant articles about pharmaceutical care in China were searched and collected in CNKI, WanFang Data, and VIP database. The bibliometric software such as Microsoft Office Excel 2017, VOSviewer 1.6.20, and CiteSpace 6.3.R2 were used to analyze the annual publication volume, author and institutional collaboration, keyword analysis in this field which could demonstrate the research status and trends.

Results  A total of 4 136 articles were included. The research in this field had gone through two stages, with a decrease in the number of publications in recent years. There were 76 core authors and 720 institutions in the field of pharmaceutical care in China. The research in pharmaceutical care in China mainly focused on case reports, with western medicine as the main research subjects. Eleven significant results were obtained by cluster analysis. The current research hotspot in this field was mainly focused on the monitoring of the use of specific drugs in some special populations.

Conclusion  The research in the field of pharmaceutical care in China developed rapidly, and the research content was relatively rich and comprehensive. However, the reports on pharmaceutical care were mostly based on individual cases and lack of experimental research. It is suggested that the relevant authors and institutions should pay close attention to the pharmaceutical care of traditional Chinese medicine and proprietary Chinese medicine while strengthening exchanges and  cooperation.

1.Ruiz-Ramos J, Hernández MH, Juanes-Borrego AM, et al. The impact of pharmaceutical care in multidisciplinary teams on health outcomes: systematic review and meta-analysis[J]. J Am Med Dir Assoc, 2021, 22(12): 2518-2526. DOI: 10.1016/j.jamda.2021.05.038.

2.Rice M, Lear A, Kane-Gill S, et al. Pharmacy personnel's involvement in transitions of care of intensive care unit patients: a systematic review[J]. J Pharm Pract, 2021, 34(1): 117-126. DOI: 10.1177/0897190020911524.

3.王玥坤, 宋娟, 冷静. 基于药物治疗管理和欧洲药学监护联盟分类系统对老年慢性病患者开展持续性药学监护实践[J]. 医学研究与战创伤救治, 2021, 34(12): 1298-1303. [Wang YK, Song J, Leng J. Practice and exploration of continuous pharmaceutical care for elderly patients with chronic diseases based on MTM and PCNE classification system[J]. Journal of Medical Research & Combat Trauma Care, 2021, 34(12): 1298-1303.] DOI: 10.16571/j.cnki.1008-8199.2021.12.012.

4.Ling J, Rao JP, Lin XS, et al. Meta-analysis of the impact of pharmaceutical care on the outcome of gestational diabetes[J]. J Holist Integr Pharm, 2023, 4(1): 68-82. DOI: 10.1016/S2707-3688(23)00096-1.

5.Morillo-Verdugo R, Calleja-Hernández MÁ, de Las Aguas Robustillo-Cortés M. A new pharmaceutical care concept: more capable, motivated, and timely[J]. Hosp Pharm, 2019, 54(6): 348-350. DOI: 10.1177/0018578719867657.

6.Gan YN, Li DD, Robinson N, et al. Practical guidance on bibliometric analysis and mapping knowledge domains methodology-a summary[J]. Eur J Integr Med, 2022, 56: 102203. DOI: 10.1016/j.eujim.2022.102203.

7.Duan H, Li J, Ma J, et al. Global research development of chondrosarcoma from 2003 to 2022: a bibliometric analysis[J]. Front Pharmacol, 2024, 15: 1431958. DOI: 10.3389/fphar.2024.1431958.

8.Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care[J]. Am J Hosp Pharm, 1990, 47(3): 533-543. DOI: 10.1093/ajhp/47.3.533.

9.吴春兴, 焦广, 郭杰. 国内细胞因子风暴研究的趋势及热点探讨[J]. 西安文理学院学报（自然科学版）, 2024, 27(3): 56-64. [Wu CX, Jiao G, Guo J. Discussion on the trends and hotspots of cytokine storm research in China[J]. Journal of Xi'an University (Natural Science Edition), 2024, 27(3): 56-64.] DOI: 10.3969/j.issn.1008- 5564.2024.03.009.

10.Wei T, Jin Q. Research trends and hotspots in exercise interventions for liver cirrhosis: a bibliometric analysis via CiteSpace[J]. Medicine (Baltimore), 2024, 103(28): e38831. DOI: 10.1097/MD.0000000000038831.

11.黄燚燚, 吴静, 李玲, 等. 1例利妥昔单抗治疗抗NMDAR脑炎患儿的药学监护[J]. 医药导报, 2022, 41(12): 1871-1875. [Huang YY, Wu J, Li L, et al. Pharmaceutical care for a child with NMDAR antibody encephalitis treated with Rituximab[J]. Herald of Medicine, 2022, 41(12): 1871-1875.] DOI: 10.3870/j.issn.1004- 0781.2022.12.026.

12.de Souza Cazarim M, Cruz-Cazarim ELC, Boyd K, et al. Effect of medication therapy management by pharmaceutical care on blood pressure and cardiovascular risk in hypertension: a systematic review, meta-analysis, and meta-regression[J]. Pharmaceuticals (Basel), 2023, 16(6): 845. DOI: 10.3390/ph16060845.

13.Kokol P, Blažun Vošner H, Završnik J. Application of bibliometrics in medicine: a historical bibliometrics analysis[J]. Health Info Libr J, 2021, 38(2): 125-138. DOI: 10.1111/hir.12295.

14.公言超. 中药学监护对临床用药的积极作用分析[J]. 智慧健康, 2024, 10(10): 79-81, 85. [Gong YC. Positive effect analysis of traditional Chinese medicine monitoring on clinical medication[J]. Smart Healthcare, 2024, 10(10): 79-81, 85.] DOI: 10.19335/j.cnki.2096-1219. 2024.10.024.

15.王晓霞, 韩媛媛, 师桂英, 等. 基于数据挖掘的中药治疗肿瘤用药分析及监护探讨[J]. 中国中药杂志, 2020, 45(2): 444-450. [Wang XX, Han YY, Shi GY, et al. Analysis and monitoring of traditional Chinese medicines for tumor based on data mining[J]. China Journal of Chinese Materia Medica, 2020, 45(2): 444-450.] DOI: 10.19540/j.cnki.cjcmm.20190513.501.

16.刘代华, 梁健成, 谢玲, 等. 临床药师对长期使用糖皮质激素患者的药学监护[J]. 中国医院药学杂志, 2013, 33(15): 1283-1285. [Liu DH, Liang JC, Xie L, et al. Pharmaceutical care of patients with long-term use of glucocorticoids by clinical pharmacists[J]. Chinese Journal of Hospital Pharmacy, 2013, 33(15): 1283-1285.] DOI: 10.13286/j.cnki.chinhosppharmacyj.2013.15.027.

17.Merks P, Cameron J, Bilmin K, et al. Medication adherence and the role of pictograms in medication counselling of chronic patients: a review[J]. Front Pharmacol, 2021, 12: 582200. DOI: 10.3389/fphar.2021.582200.

18.Bai J, Liu J, Ji X, et al. Therapeutic drug monitoring-guided vancomycin therapy of a pediatric patient after liver transplantation: a case report[J]. Clin Lab, 2023, 69(10): 2147-2151. DOI: 10.7754/Clin.Lab.2023.230209.

19.Zhou B, Xiong W, Bai K, et al. Clinical application value of pharmacokinetic parameters of vancomycin in children treated in the pediatric intensive care unit[J]. Front Pediatr, 2022, 10: 867712. DOI: 10.3389/fped.2022.867712.

20.姜惠婷. 基于TDM的重症患者万古霉素个体化药学监护研究[D]. 延边: 延边大学, 2022. [Jiang HT. Study on individualized pharmaceutical care for critically ill patients treated with vancomycin based on TDM[D]. Yanbian: Yanbian University, 2022.] DOI: 10.27439/d.cnki.gybdu.2022.000723.

21.马春来, 钟明康, 甄健存, 等. 《用药监护标准》制订与解析[J]. 医药导报, 2023, 42(11): 1615-1618. [MA CL, Zhong MK, Zhen JC, et al. Formulation and analysis on the Standard of Drug Monitoring[J]. Herald of Medicine, 2023, 42(11): 1615-1618.] DOI: 10.3870/j.issn.1004- 0781.2023.11.004.

22.Kramer JS, Borum C, Claxon EL, et al. Impact of clinical pharmacy surveillance on pharmacy services: a quality improvement project[J]. J Healthc Manag, 2023, 68(5): 312-324. DOI: 10.1097/JHM-D-22-00176.

23.侯文婧, 卜一珊, 金朝辉, 等. 医疗机构药学服务规范第7部分用药监护[J]. 中国药房, 2019, 30(24): 3318-3321, 3324. [Hou WJ, Bu YS, Jin CH, et al. Pharmaceutical service standards for medical institutions Part 7 Pharmaceutical care[J]. China Pharmacy, 2019, 30(24): 3318-3321, 3324.] https://www.cnki.com.cn/Article/CJFDTotal-ZGYA201924004.htm

24.吴汀溪, 余俊先, 邢云利, 等. 利用欧洲药学监护网络分类系统对老年慢病患者用药分析[J]. 医药导报, 2020, 39(2): 168-171. [Wu TX, Yu JX, Xing YL, et al. Analysis of drug use of elderly patients with chronic disease by pharmaceutical care network Europe classification system[J]. Herald of Medicine, 2020, 39(2): 168-171.] DOI: 10.3870/j.issn.1004-0781.2020.02.008.

25.Shinu C, Dilip C. Impact of pharmaceutical care programme on health outcome of geriatric patients[J]. Clin Epidemiol Glob Health, 2020, 8(3): 894-898. DOI: 10.1016/j.cegh.2020.02.019.